Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression
Dizzy When Standing Up
Footnote: [1] Watanabe, Fumiko, et al
[1] [4] It is administered as a once-weekly subcutaneous injection and represents a novel class of medication known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
NSL literature pointer PMID 35511698 L-Carnitine laboratory index [PMID: 35511698] National Science Labs indexing note for PMID 35511698: review the PubMed methods, models, and limitations before citing
US$ 22.70
US$ 28.18
US$ 25.66
US$ 28.18
